FORM 6-K
 

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 


For period ending June 2009
 

GlaxoSmithKline plc
(Name of registrant)
 
 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 

Form 20-F x Form 40-F
 

 --

Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
Yes No x
  --

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons



I give below details of 
a 
change
 in interest
 in the Ordinary s
hares of GlaxoSmithKline plc in respect of the under-mentioned per
son
, arising
 from the purchase of 
an 
Ordinary s
hare on 
4 June
 2009
 following the reinvestment of
 the
 
cash reserve
 
on shares held within an
 
ISA
 at a price of £
10.36
 
per Ordinary s
hare:

Mr A P Witty

1



The Company and 
the above named person
s were advised of this information 
on 
10 June
 2009
.

This notification relates to a transaction notified in accordance with
 
Disclosure 
and Transparency 
Rule 3.1.4R(1)(a).

S M Bicknell
Company Secretary

11 June
 2009

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 

GlaxoSmithKline plc
(Registrant)
 
 

Date: June 11 2009

By: VICTORIA WHYTE

------------------

Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc